array(40) {
  [0]=>
  string(4) "8702"
  ["article_id"]=>
  string(4) "8702"
  [1]=>
  string(63) "Laboratory equipment supplier can help with coronavirus testing"
  ["article_title"]=>
  string(63) "Laboratory equipment supplier can help with coronavirus testing"
  [2]=>
  string(107) "Alpha Laboratories, a laboratory equipment supplier, has released a statement during the COVID-19 pandemic."
  ["short_description"]=>
  string(107) "Alpha Laboratories, a laboratory equipment supplier, has released a statement during the COVID-19 pandemic."
  [3]=>
  string(107) "Alpha Laboratories, a laboratory equipment supplier, has released a statement during the COVID-19 pandemic."
  ["description"]=>
  string(107) "Alpha Laboratories, a laboratory equipment supplier, has released a statement during the COVID-19 pandemic."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(94) "https://www.medicalplasticsnews.com/news/alpha-laboratories-can-help-with-coronavirus-testing/"
  ["blog_url"]=>
  string(94) "https://www.medicalplasticsnews.com/news/alpha-laboratories-can-help-with-coronavirus-testing/"
  [15]=>
  string(19) "2020-03-24 18:12:23"
  ["add_date"]=>
  string(19) "2020-03-24 18:12:23"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:40"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8560"
  ["article_id"]=>
  string(4) "8560"
  [1]=>
  string(142) "Two Additional Coronavirus Patients Treated at Leading New York Hospital with CytoDyn’s Leronlimab, Bringing the Total to Four Patients"
  ["article_title"]=>
  string(142) "Two Additional Coronavirus Patients Treated at Leading New York Hospital with CytoDyn’s Leronlimab, Bringing the Total to Four Patients"
  [2]=>
  string(154) "VANCOUVER, Washington, March 23, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-sta"
  ["short_description"]=>
  string(154) "VANCOUVER, Washington, March 23, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-sta"
  [3]=>
  string(255) "VANCOUVER, Washington, March 23, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for..."
  ["description"]=>
  string(255) "VANCOUVER, Washington, March 23, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/two-additional-coronavirus-patients-treated-leading-new-york-hospital-cytodyn-s-leronlimab-bringing-18485.html?utm_source=ddc&utm_medium=rss&utm_campaign=Two+Additional+Coronavirus+Patients+Treated+at+Leading+New+York+Hospital+with+CytoDyn%E2%80%99s+Leronlimab%2"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/two-additional-coronavirus-patients-treated-leading-new-york-hospital-cytodyn-s-leronlimab-bringing-18485.html?utm_source=ddc&utm_medium=rss&utm_campaign=Two+Additional+Coronavirus+Patients+Treated+at+Leading+New+York+Hospital+with+CytoDyn%E2%80%99s+Leronlimab%2"
  [15]=>
  string(19) "2020-03-24 07:03:54"
  ["add_date"]=>
  string(19) "2020-03-24 07:03:54"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:18:05"
  ["create_at"]=>
  string(19) "2020-03-31 11:18:05"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8747"
  ["article_id"]=>
  string(4) "8747"
  [1]=>
  string(64) "Stratasys Increasing Production of Personal Protection Equipment"
  ["article_title"]=>
  string(64) "Stratasys Increasing Production of Personal Protection Equipment"
  [2]=>
  string(163) "&#nl        EDEN PRAIRIE, MN — Stratasys Ltd. has announced a global mobilization of the company’s 3D printing resources and expertise to respond to "
  ["short_description"]=>
  string(163) "&#nl        EDEN PRAIRIE, MN — Stratasys Ltd. has announced a global mobilization of the company’s 3D printing resources and expertise to respond to "
  [3]=>
  string(300) "&#nl        EDEN PRAIRIE, MN — Stratasys Ltd. has announced a global mobilization of the company’s 3D printing resources and expertise to respond to the COVID-19 pandemic with the initial focus is on providing thousands of disposable face shields for use by medical personnel.&#nl      "
  ["description"]=>
  string(300) "&#nl        EDEN PRAIRIE, MN — Stratasys Ltd. has announced a global mobilization of the company’s 3D printing resources and expertise to respond to the COVID-19 pandemic with the initial focus is on providing thousands of disposable face shields for use by medical personnel.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "99"
  ["rss_id"]=>
  string(2) "99"
  [14]=>
  string(107) "https://www.assemblymag.com/articles/95540-stratasys-increasing-production-of-personal-protection-equipment"
  ["blog_url"]=>
  string(107) "https://www.assemblymag.com/articles/95540-stratasys-increasing-production-of-personal-protection-equipment"
  [15]=>
  string(19) "2020-03-23 23:41:36"
  ["add_date"]=>
  string(19) "2020-03-23 23:41:36"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:24:13"
  ["create_at"]=>
  string(19) "2020-03-31 11:24:13"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8546"
  ["article_id"]=>
  string(4) "8546"
  [1]=>
  string(72) "Paracetamol sold for more than £50 per tablet on online bidding sites"
  ["article_title"]=>
  string(72) "Paracetamol sold for more than £50 per tablet on online bidding sites"
  [2]=>
  string(150) "Packets of paracetamol are being sold via online bidding sites at increasingly inflated prices amid concerns around shortages resulting from the COVID"
  ["short_description"]=>
  string(150) "Packets of paracetamol are being sold via online bidding sites at increasingly inflated prices amid concerns around shortages resulting from the COVID"
  [3]=>
  string(204) "Packets of paracetamol are being sold via online bidding sites at increasingly inflated prices amid concerns around shortages resulting from the COVID-19 pandemic, The Pharmaceutical Journal has found."
  ["description"]=>
  string(204) "Packets of paracetamol are being sold via online bidding sites at increasingly inflated prices amid concerns around shortages resulting from the COVID-19 pandemic, The Pharmaceutical Journal has found."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(147) "https://www.pharmaceutical-journal.com/news-and-analysis/news/paracetamol-sold-for-more-than-50-per-tablet-on-online-bidding-sites/20207846.article"
  ["blog_url"]=>
  string(147) "https://www.pharmaceutical-journal.com/news-and-analysis/news/paracetamol-sold-for-more-than-50-per-tablet-on-online-bidding-sites/20207846.article"
  [15]=>
  string(19) "2020-03-23 22:52:00"
  ["add_date"]=>
  string(19) "2020-03-23 22:52:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:18:02"
  ["create_at"]=>
  string(19) "2020-03-31 11:18:02"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8703"
  ["article_id"]=>
  string(4) "8703"
  [1]=>
  string(34) "Notified bodies: Where are we now?"
  ["article_title"]=>
  string(34) "Notified bodies: Where are we now?"
  [2]=>
  string(150) "As the EU Medical Device Regulation (MDR) deadline is rapidly approaching, our editor Laura Hughes takes a look at how many notified bodies have been "
  ["short_description"]=>
  string(150) "As the EU Medical Device Regulation (MDR) deadline is rapidly approaching, our editor Laura Hughes takes a look at how many notified bodies have been "
  [3]=>
  string(199) "As the EU Medical Device Regulation (MDR) deadline is rapidly approaching, our editor Laura Hughes takes a look at how many notified bodies have been successfully appointed ahead of the May deadline."
  ["description"]=>
  string(199) "As the EU Medical Device Regulation (MDR) deadline is rapidly approaching, our editor Laura Hughes takes a look at how many notified bodies have been successfully appointed ahead of the May deadline."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(74) "https://www.medicalplasticsnews.com/news/notified-bodies-where-are-we-now/"
  ["blog_url"]=>
  string(74) "https://www.medicalplasticsnews.com/news/notified-bodies-where-are-we-now/"
  [15]=>
  string(19) "2020-03-23 19:20:16"
  ["add_date"]=>
  string(19) "2020-03-23 19:20:16"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:40"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8704"
  ["article_id"]=>
  string(4) "8704"
  [1]=>
  string(71) "Medtronic increases ventilator production to cope with increased demand"
  ["article_title"]=>
  string(71) "Medtronic increases ventilator production to cope with increased demand"
  [2]=>
  string(150) "Medtronic has increased its ventilator production by more than 40%, and is on track to more than double its capacity to manufacture and supply ventila"
  ["short_description"]=>
  string(150) "Medtronic has increased its ventilator production by more than 40%, and is on track to more than double its capacity to manufacture and supply ventila"
  [3]=>
  string(199) "Medtronic has increased its ventilator production by more than 40%, and is on track to more than double its capacity to manufacture and supply ventilators in response to demand triggered by COVID-19."
  ["description"]=>
  string(199) "Medtronic has increased its ventilator production by more than 40%, and is on track to more than double its capacity to manufacture and supply ventilators in response to demand triggered by COVID-19."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(102) "https://www.medicalplasticsnews.com/news/medtronic-increases-manufacturing-capacity-to-cope-with-incr/"
  ["blog_url"]=>
  string(102) "https://www.medicalplasticsnews.com/news/medtronic-increases-manufacturing-capacity-to-cope-with-incr/"
  [15]=>
  string(19) "2020-03-23 18:33:13"
  ["add_date"]=>
  string(19) "2020-03-23 18:33:13"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:40"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8608"
  ["article_id"]=>
  string(4) "8608"
  [1]=>
  string(81) "Coloplast A/S - Transactions in connection with share buy-back programme, week 12"
  ["article_title"]=>
  string(81) "Coloplast A/S - Transactions in connection with share buy-back programme, week 12"
  [2]=>
  string(123) "As mentioned in Announcement no. 02/2020 Coloplast is initiating a share buyback programme totalling up to DKK 500 million."
  ["short_description"]=>
  string(123) "As mentioned in Announcement no. 02/2020 Coloplast is initiating a share buyback programme totalling up to DKK 500 million."
  [3]=>
  string(134) "
As mentioned in Announcement no. 02/2020 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.
"
  ["description"]=>
  string(134) "
As mentioned in Announcement no. 02/2020 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "27"
  ["rss_id"]=>
  string(2) "27"
  [14]=>
  string(149) "http://www.globenewswire.com/news-release/2020/03/23/2004549/0/en/Coloplast-A-S-Transactions-in-connection-with-share-buy-back-programme-week-12.html"
  ["blog_url"]=>
  string(149) "http://www.globenewswire.com/news-release/2020/03/23/2004549/0/en/Coloplast-A-S-Transactions-in-connection-with-share-buy-back-programme-week-12.html"
  [15]=>
  string(19) "2020-03-23 17:54:00"
  ["add_date"]=>
  string(19) "2020-03-23 17:54:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:24"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8609"
  ["article_id"]=>
  string(4) "8609"
  [1]=>
  string(78) "Coloplast A/S - Transaktioner i henhold til aktietilbagekøbsprogram, uge 12"
  ["article_title"]=>
  string(78) "Coloplast A/S - Transaktioner i henhold til aktietilbagekøbsprogram, uge 12"
  [2]=>
  string(133) "Som meddelt i Selskabsmeddelelse nr. 02/2020 har Coloplast iværksat et tilbagekøbsprogram på i alt 500 millioner kroner. "
  ["short_description"]=>
  string(133) "Som meddelt i Selskabsmeddelelse nr. 02/2020 har Coloplast iværksat et tilbagekøbsprogram på i alt 500 millioner kroner. "
  [3]=>
  string(144) "
Som meddelt i Selskabsmeddelelse nr. 02/2020 har Coloplast iværksat et tilbagekøbsprogram på i alt 500 millioner kroner. 
"
  ["description"]=>
  string(144) "
Som meddelt i Selskabsmeddelelse nr. 02/2020 har Coloplast iværksat et tilbagekøbsprogram på i alt 500 millioner kroner. 
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "27"
  ["rss_id"]=>
  string(2) "27"
  [14]=>
  string(148) "http://www.globenewswire.com/news-release/2020/03/23/2004549/0/da/Coloplast-A-S-Transaktioner-i-henhold-til-aktietilbagek%C3%B8bsprogram-uge-12.html"
  ["blog_url"]=>
  string(148) "http://www.globenewswire.com/news-release/2020/03/23/2004549/0/da/Coloplast-A-S-Transaktioner-i-henhold-til-aktietilbagek%C3%B8bsprogram-uge-12.html"
  [15]=>
  string(19) "2020-03-23 17:54:00"
  ["add_date"]=>
  string(19) "2020-03-23 17:54:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:24"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8705"
  ["article_id"]=>
  string(4) "8705"
  [1]=>
  string(75) "Q&A: Bright Machines CEO on combatting potential COVID-19 related shortages"
  ["article_title"]=>
  string(75) "Q&A: Bright Machines CEO on combatting potential COVID-19 related shortages"
  [2]=>
  string(162) "Web content editor Ian Bolland caught up with CEO Amar Hanspal to find out more about smart manufacturer Bright Machines' new initiative to combat"
  ["short_description"]=>
  string(162) "Web content editor Ian Bolland caught up with CEO Amar Hanspal to find out more about smart manufacturer Bright Machines' new initiative to combat"
  [3]=>
  string(228) "Web content editor Ian Bolland caught up with CEO Amar Hanspal to find out more about smart manufacturer Bright Machines' new initiative to combat potential medical product shortages during the COVID-19 pandemic."
  ["description"]=>
  string(228) "Web content editor Ian Bolland caught up with CEO Amar Hanspal to find out more about smart manufacturer Bright Machines' new initiative to combat potential medical product shortages during the COVID-19 pandemic."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(115) "https://www.medicalplasticsnews.com/mpn-north-america/q-a-bright-machines-ceo-on-combatting-potential-covid-19-rel/"
  ["blog_url"]=>
  string(115) "https://www.medicalplasticsnews.com/mpn-north-america/q-a-bright-machines-ceo-on-combatting-potential-covid-19-rel/"
  [15]=>
  string(19) "2020-03-23 17:26:35"
  ["add_date"]=>
  string(19) "2020-03-23 17:26:35"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:40"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8549"
  ["article_id"]=>
  string(4) "8549"
  [1]=>
  string(54) "How employers can help support staff with disabilities"
  ["article_title"]=>
  string(54) "How employers can help support staff with disabilities"
  [2]=>
  string(126) "Employers have a duty of care to support the health, safety and wellbeing of all employees, including those with disabilities."
  ["short_description"]=>
  string(126) "Employers have a duty of care to support the health, safety and wellbeing of all employees, including those with disabilities."
  [3]=>
  string(126) "Employers have a duty of care to support the health, safety and wellbeing of all employees, including those with disabilities."
  ["description"]=>
  string(126) "Employers have a duty of care to support the health, safety and wellbeing of all employees, including those with disabilities."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "12"
  ["rss_id"]=>
  string(2) "12"
  [14]=>
  string(159) "https://www.pharmaceutical-journal.com/careers-and-jobs/careers-and-jobs/career-feature/how-employers-can-help-support-staff-with-disabilities/20207690.article"
  ["blog_url"]=>
  string(159) "https://www.pharmaceutical-journal.com/careers-and-jobs/careers-and-jobs/career-feature/how-employers-can-help-support-staff-with-disabilities/20207690.article"
  [15]=>
  string(19) "2020-03-23 16:46:00"
  ["add_date"]=>
  string(19) "2020-03-23 16:46:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:18:04"
  ["create_at"]=>
  string(19) "2020-03-31 11:18:04"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8706"
  ["article_id"]=>
  string(4) "8706"
  [1]=>
  string(82) "MedScan3D offers to produce items required quickly for hospitals battling COVID-19"
  ["article_title"]=>
  string(82) "MedScan3D offers to produce items required quickly for hospitals battling COVID-19"
  [2]=>
  string(150) "MedScan3D, a division within 3D Technology, has expressed its openness to help supply hospitals with necessities that may be running low as they tackl"
  ["short_description"]=>
  string(150) "MedScan3D, a division within 3D Technology, has expressed its openness to help supply hospitals with necessities that may be running low as they tackl"
  [3]=>
  string(177) "MedScan3D, a division within 3D Technology, has expressed its openness to help supply hospitals with necessities that may be running low as they tackle the Coronavirus outbreak."
  ["description"]=>
  string(177) "MedScan3D, a division within 3D Technology, has expressed its openness to help supply hospitals with necessities that may be running low as they tackle the Coronavirus outbreak."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(102) "https://www.medicalplasticsnews.com/news/medscan3d-offers-to-produce-items-required-quickly-for-hospi/"
  ["blog_url"]=>
  string(102) "https://www.medicalplasticsnews.com/news/medscan3d-offers-to-produce-items-required-quickly-for-hospi/"
  [15]=>
  string(19) "2020-03-23 15:50:47"
  ["add_date"]=>
  string(19) "2020-03-23 15:50:47"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:40"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8561"
  ["article_id"]=>
  string(4) "8561"
  [1]=>
  string(76) "Gilead Sciences Statement on Access to Remdesivir Outside of Clinical Trials"
  ["article_title"]=>
  string(76) "Gilead Sciences Statement on Access to Remdesivir Outside of Clinical Trials"
  [2]=>
  string(150) "March 22, 2020 -- Gilead is working to rapidly assess the safety and efficacy of remdesivir as a potential treatment for COVID-19 through multiple ong"
  ["short_description"]=>
  string(150) "March 22, 2020 -- Gilead is working to rapidly assess the safety and efficacy of remdesivir as a potential treatment for COVID-19 through multiple ong"
  [3]=>
  string(247) "March 22, 2020 -- Gilead is working to rapidly assess the safety and efficacy of remdesivir as a potential treatment for COVID-19 through multiple ongoing clinical trials. Enrollment in clinical trials is the primary way to access remdesivir to..."
  ["description"]=>
  string(247) "March 22, 2020 -- Gilead is working to rapidly assess the safety and efficacy of remdesivir as a potential treatment for COVID-19 through multiple ongoing clinical trials. Enrollment in clinical trials is the primary way to access remdesivir to..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(236) "https://www.drugs.com/clinical_trials/gilead-sciences-statement-access-remdesivir-outside-clinical-trials-18467.html?utm_source=ddc&utm_medium=rss&utm_campaign=Gilead+Sciences+Statement+on+Access+to+Remdesivir+Outside+of+Clinical+Trials"
  ["blog_url"]=>
  string(236) "https://www.drugs.com/clinical_trials/gilead-sciences-statement-access-remdesivir-outside-clinical-trials-18467.html?utm_source=ddc&utm_medium=rss&utm_campaign=Gilead+Sciences+Statement+on+Access+to+Remdesivir+Outside+of+Clinical+Trials"
  [15]=>
  string(19) "2020-03-23 05:03:11"
  ["add_date"]=>
  string(19) "2020-03-23 05:03:11"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:18:05"
  ["create_at"]=>
  string(19) "2020-03-31 11:18:05"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}